SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Barr Laboratory BRL -- Ignore unavailable to you. Want to Upgrade?


To: harkenman who wrote (169)6/18/1999 10:47:00 AM
From: E. Graphs  Respond to of 207
 
Nope.........just innocently watching the chart.......0:)



To: harkenman who wrote (169)6/18/1999 11:17:00 AM
From: E. Graphs  Read Replies (1) | Respond to of 207
 
Barr upgraded from neutral to buy

biz.yahoo.com

Hey, wasn't this the same guy who downgraded from buy to neutral on March 17th? Look what happened on March 17th! Shouldn't we have an equal and opposite reaction now that he has flipped??

exchange2000.com

>>In addition to Elliot Wilbur, CFA, Specialty Pharmaceuticals of CIBC Oppenheimer, Barr's performance is now followed by: Kenneth R. Kulju, Equity Research Analyst, Specialty Pharmaceuticals, Donaldson, Lufkin & Jenrette; David F. Saks, Managing Director, Gruntal & Co., L.L.C.; David G. Buck, Analyst, Sands Brothers & Co. Ltd.; Michael K. Tong, Ph.D., Equity Analyst, Salomon Smith Barney; and, Jerry I. Treppel, CFA, Warburg Dillon Read.<<

(5/14/99)
go2net.newsalert.com